---
$id: https://graph.org.ai/products/commodity/51111805
$type: Product
source: UNSPSC
code: "51111805"
title: "Goserelin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Goserelin

**UNSPSC Code**: 51111805
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin-releasing hormone analog with the molecular formula C59H84N18O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0F65R8P09N, chemically known as luteinizing hormone-releasing factor (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide but generally known as goserelin, which bears US NIH Compound Identifier 47725. European Medicines Agency schedules Goserelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07962MIG. The term GOSERELIN is an International Non-Proprietary Name. World Health Organization schedules goserelin in its Anatomical Therapeutic Chemical (ATC) Classification. GOSERELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule goserelin under HS 29371900 and SITC 54154. As of Q4 2014, GOSERELIN remains the US FDA Preferred Term for this commodity. Goserelin bears US NLM identifiers UMLS ID C0120107 and NCI Concept Code C1374. SMILES: O=C(N1C(CCC1)C(=O)NNC(=O)N)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1[NH]CNC1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)COC(C)(C)C)CC(C)C)CCC/N=C(/N)N.

